Back to ACAD
MACKENZIE FINANCIAL CORP → ACAD
MACKENZIE FINANCIAL CORP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$8.3M
Q3 2026
Peak value
$10.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q4 2025 | $1.5M |
| Q1 2026 | $2.3M |
| Q2 2026 | $10.6M |
| Q3 2026 | $8.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.3M | 413.1K | — | — |
| Q2 2026 | $10.6M | 420.8K | — | — |
| Q1 2026 | $2.3M | 101.3K | — | — |
| Q4 2025 | $1.5M | 57.3K | — | — |
| Q3 2025 | $1.1M | 53.4K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M